Biblio Discovery — Demo Discovery Service

11 results for "Benjamin Rolles"

Showing 1–11 · 0.56 seconds · RSS

  1. Journal Article Full text

    The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis

    Inga Wessels; Benjamin Rolles; Lothar Rink

    Frontiers in Immunology, Vol. 11 · 2020 · English · DOAJ Scopus

    During the current corona pandemic, new therapeutic options against this viral disease are urgently desired. Due to the rapid spread and immense number of affected individuals worldwide, cost-effective, globally available, and safe options with minimal side effects and simple application are…

    Also available at: OpenAlex

  2. Journal Article

    Retrospective observational study evaluating zinc plasma level in patients undergoing thoracoabdominal aortic aneurysm repair and its correlation with outcome

    Benjamin Rolles; Inga Wessels; Panagiotis Doukas et al.

    Scientific Reports, Vol. 11 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Thoracoabdominal aortic aneurysm (TAAA) repair is related to a relevant morbidity and in-hospital mortality rate. In this retrospective observational single-center study including serum zinc levels of 33 patients we investigated the relationship between zinc and patients’ outcome following…

  3. Journal Article

    Eltrombopag Preserves the Clonogenic Potential of Hematopoietic Stem Cells During Treatment With Antithymocyte Globulin in Patients With Aplastic Anemia

    Margherita Vieri; Benjamin Rolles; Maria Crocioni et al.

    HemaSphere, Vol. 7 No. 6 · 2023 · English · DOAJ Scopus

    Aplastic anemia (AA) is frequently caused by a T-cell mediated autoimmune depletion of the hematopoietic stem and progenitor cell (HSPC) compartment. Immunosuppressive therapy (IST) with antithymocyte globulin (ATG) and cyclosporine represents the first-line treatment of AA. One side effect of ATG…

  4. Journal Article

    Telomere Shortening in Peripheral Leukocytes Is Associated With Poor Survival in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy

    Benjamin Rolles; Joao Gorgulho; Mareike Tometten et al.

    Frontiers in Oncology, Vol. 11 · 2021 · English · DOAJ Scopus

    BackgroundImmune checkpoint inhibitor (ICI) therapy represents a new standard of care for an increasing number of malignancies. Nevertheless, response rates and outcome of ICI treatment vary between individuals and the identification of predictive markers or hints towards immune cell exhaustion…

  5. Journal Article

    Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1)

    Patrick P. Hess; Monica S. Ventura Ferreira; Benjamin Rolles et al.

    Clinical Case Reports, Vol. 10 No. 5 · 2022 · English · DOAJ Dropped by Scopus 2021

    Abstract Treatment for Hodgkin lymphoma (HL) in adults comprises substantial risk of chemotherapy‐induced peripheral neurotoxicity. Here, we describe the case of patient with Charcot–Marie–Tooth disease or HSMN1 and advanced Hodgkin lymphoma undergoing treatment with modified BEACOPP achieving…

  6. Journal Article

    Telomere length dynamics measured by flow-FISH in patients with obesity undergoing bariatric surgery

    Benjamin Rolles; Monica S. V. Ferreira; Margherita Vieri et al.

    Scientific Reports, Vol. 13 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Obesity has negative effects on comorbidities, health-related quality of life and survival. Telomere length (TL) changes after bariatric surgery have been reported, but the studies are contradictory, and analyses using state-of-the art techniques for TL measurement, such as flow-FISH, are…

  7. Journal Article

    Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax—an analysis from the International Consortium for MDS (icMDS) VALIDATE database

    Jan Philipp Bewersdorf; Tariq Kewan; Luca Lanino et al.

    Blood Cancer Journal, Vol. 16 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Monotherapy with hypomethylating agents (HMA) remains the standard of care for patients with higher-risk myelodysplastic neoplasms (HR-MDS). Recently, the randomized phase III VERONA study evaluating azacitidine plus venetoclax (VEN) versus azacitidine plus placebo in newly diagnosed…